Asset
Acalabrutinib maleate anhydrous
AstraZeneca PLC Ordinary Shares
Revenue
No revenue reported in loaded filings.
Clinical trials (0)
No records yet.
FDA applications (1)
| Application | Type | Applicant |
|---|---|---|
| NDA 216387 | NDA | ASTRAZENECA UK LTD |
Marketed products (1)
- CALQUENCE